These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 6784922)
1. Hexamethylmelamine, doxorubicin, and cyclophosphamide in advanced ovarian cancer resistant to previous chemotherapy. Sessa C; Bolis G; Valente I; Mangioni C; D'Incalci M Cancer Treat Rep; 1981; 65(1-2):172-3. PubMed ID: 6784922 [No Abstract] [Full Text] [Related]
2. Combination chemotherapy for advanced ovarian cancer: a prospective randomized trial comparing hexamethylmelamine and cyclophosphamide to doxorubicin and cyclophosphamide. Schwartz PE; Lawrence R; Katz M Cancer Treat Rep; 1981; 65(1-2):137-41. PubMed ID: 6261948 [TBL] [Abstract][Full Text] [Related]
3. Hexamethylmelamine-CAF (cyclophosphamide, methotrexate, and 5-FU) and cisplatin-CAF in refractory ovarian cancer. Sessa C; D'Incalci M; Valente I; Bolis G; Colombo N; Mangioni C Cancer Treat Rep; 1982 May; 66(5):1233-4. PubMed ID: 6805951 [No Abstract] [Full Text] [Related]
4. Hexa-CAF combination chemotherapy and other multiple-drug regimens in advanced ovarian carcinoma: present and future. Neijt JP; van Lindert AC; Vendrik CP; Roozendaal KJ; Struyvenberg A; Pinedo HM Neth J Med; 1979; 22(2):38-44. PubMed ID: 107464 [No Abstract] [Full Text] [Related]
5. Hexamethylmelamine in ovarian cancer resistant to cyclophosphamide and adriamycin. Bolis G; D'Incalci M; Belloni C; Mangioni C Cancer Treat Rep; 1979 Aug; 63(8):1375-7. PubMed ID: 113096 [TBL] [Abstract][Full Text] [Related]
6. Single-agent adriamycin followed by combination hexamethylmelamine-cyclophosphamide for advanced ovarian carcinoma. Wharton JT; Herson J; Edwards CL; Griffith AB Gynecol Oncol; 1982 Oct; 14(2):262-70. PubMed ID: 6813202 [No Abstract] [Full Text] [Related]
7. Cyclophosphamide, hexamethylmelamine, doxorubicin, and cisplatin (CHAD) as second-line chemotherapy for ovarian adenocarcinoma. Piver MS; Lele S; Barlow JJ Cancer Treat Rep; 1981; 65(1-2):149-51. PubMed ID: 6784921 [TBL] [Abstract][Full Text] [Related]
8. The application of dose intensity to problems in chemotherapy of ovarian and endometrial cancer. Levin L; Hryniuk W Semin Oncol; 1987 Dec; 14(4 Suppl 4):12-9. PubMed ID: 3120317 [TBL] [Abstract][Full Text] [Related]
9. Phase II study of cyclophosphamide and hexamethylmelamine in non-oat cell bronchogenic carcinoma. Pisoni MB; Libretti A; Piazza E; Vago G; Scapaticci R; Bianchi C; Tomirotti M; Scanni A; Calzavara MP; Cassani L; Scarpazza G; Marsoni S; Morasca L Cancer Treat Rep; 1981; 65(7-8):731-2. PubMed ID: 6788372 [No Abstract] [Full Text] [Related]
11. Combination chemotherapy of advanced ovarian cancer with hexamethylmelamine, cis-Platinum, and doxorubicin after failure of prior therapy. Vogl SE; Pagano M; Kaplan BH; Einhorn N; Arseneau J; Moukhtar M; Greenwald E Obstet Gynecol; 1980 Nov; 56(5):635-40. PubMed ID: 6776457 [TBL] [Abstract][Full Text] [Related]
12. Treatment of chemotherapy-resistant advanced ovarian cancer with a combination of cyclophosphamide, hexamethylmelamine, adriamycin, and cis-diamminedichloroplatinum (CHAP). Bruckner HW; Cohen CJ; Deppe G; Kabakow B; Wallach R; Ratner L; Holland JF Gynecol Oncol; 1981 Oct; 12(2 Pt 1):150-3. PubMed ID: 6795095 [No Abstract] [Full Text] [Related]
13. [Progress in the chemotherapy of ovarian cancer]. Honetz N Wien Med Wochenschr; 1982 Jul; 132(13-14):319-24. PubMed ID: 6291259 [No Abstract] [Full Text] [Related]
14. Hexamethylmelamine and cisplatin in advanced ovarian cancer after failure of alkylating-agent therapy. Vogl SE; Pagano M; Davis TE; Einhorn N; Tunca JC; Kaplan BH; Arseneau JC Cancer Treat Rep; 1982 Jun; 66(6):1285-90. PubMed ID: 6282454 [TBL] [Abstract][Full Text] [Related]
15. Randomized trial of initial therapy with melphalan versus cisplatin-based combination chemotherapy in patients with advanced ovarian carcinoma: initial and long term results--Eastern Cooperative Oncology Group Study E2878. Wadler S; Yeap B; Vogl S; Carbone P Cancer; 1996 Feb; 77(4):733-42. PubMed ID: 8616766 [TBL] [Abstract][Full Text] [Related]
16. A randomized comparison of melphalan versus melphalan plus hexamethylmelamine versus adriamycin plus cyclophosphamide in ovarian carcinoma. Omura GA; Morrow CP; Blessing JA; Miller A; Buchsbaum HJ; Homesley HD; Leone L Cancer; 1983 Mar; 51(5):783-9. PubMed ID: 6401594 [TBL] [Abstract][Full Text] [Related]
17. cis-Platinum, adriamycin, and hexamethylmelamine versus cyclophosphamide in advanced ovarian carcinoma. Carmo-Pereira J; Costa FO; Henriques E Cancer Chemother Pharmacol; 1983; 10(2):100-3. PubMed ID: 6403254 [TBL] [Abstract][Full Text] [Related]
19. [Chemotherapy in advanced forms of carcinoma of the ovary]. Calciati A; Clerico M; Donadio M; Giaccone G Minerva Ginecol; 1984 Apr; 36(4):195-8. PubMed ID: 6431334 [No Abstract] [Full Text] [Related]
20. Controlled prospective trial of combination chemotherapy with cyclophosphamide, adriamycin, and 5-fluorouracil for the treatment of advanced ovarian cancer: a preliminary report. Bruckner HW; Pagano M; Falkson G; Creech R; Arseneau JC; Horton J; Brodovsky H; Davis TE; Slayton RW; Greenspan E Cancer Treat Rep; 1979 Feb; 63(2):297-9. PubMed ID: 376136 [No Abstract] [Full Text] [Related] [Next] [New Search]